Array
(
[id] => 9581693
[patent_doc_number] => 08771694
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-08
[patent_title] => 'Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells'
[patent_app_type] => utility
[patent_app_number] => 09/988013
[patent_app_country] => US
[patent_app_date] => 2001-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 10757
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 259
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 09988013
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/988013 | Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells | Nov 15, 2001 | Issued |
Array
(
[id] => 295767
[patent_doc_number] => 07541034
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-06-02
[patent_title] => 'Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors'
[patent_app_type] => utility
[patent_app_number] => 09/381497
[patent_app_country] => US
[patent_app_date] => 1998-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 16844
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/541/07541034.pdf
[firstpage_image] =>[orig_patent_app_number] => 09381497
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/381497 | Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors | Mar 18, 1998 | Issued |